Replimune Group, Inc. (REPL)
8.865
-0.10
(-1.17%)
USD |
NASDAQ |
Jun 09, 13:54
Replimune Group Shareholders Equity (Quarterly) : 210.54M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.500B |
| Oncolytics Biotech, Inc. | -5.13M |
| Rocket Pharmaceuticals, Inc. | 238.04M |
| Cogent Biosciences, Inc. | 607.69M |
| Lantern Pharma, Inc. | 3.446M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 333.59M |
| Total Liabilities (Quarterly) | 123.05M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |